Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies

被引:50
作者
Coudeville, L. [1 ]
Van Rie, A. [2 ]
Andre, P. [1 ]
机构
[1] Sanofi Pasteur, Lyon, France
[2] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
关键词
D O I
10.1017/S0950268807009041
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A compartmental, age-structured mathematical model was developed and recent US pertussis epidemiology data were used to evaluate the impact on pertussis infection rates of routine and target adult immunization strategies. Model simulations predict that the implementation of adolescent immunization only could reverse the current rise in pertussis infection rates but may lead to a resurgence of pertussis in subsequent decades. In contrast, inclusion of a routine adult strategy is likely to lead to sustained control of pertussis. Routine adult vaccination could control the disease even with relatively low coverage rates of 40% for routine vaccination of all adults every 10 years, or 65% for a targeted vaccination of close contacts of newborns completed by one booster dose for all adults. The model also predicts that the optimal age for this booster dose is 40 years. These results support the 2006 American Academy of Immunization Practices' recommendations for adolescent and adult vaccination against pertussis.
引用
收藏
页码:604 / 620
页数:17
相关论文
共 19 条
  • [1] Effectiveness of pertussis vaccine during outbreaks in schools and centers for disabled children.
    Baron, S
    Grimprel, E
    Daurat, G
    Cuisinet, C
    Ponge, A
    Haeghebaert, S
    Guiso, N
    Desenclos, JC
    Drucker, J
    [J]. ARCHIVES DE PEDIATRIE, 1997, 4 (08): : 744 - 750
  • [2] Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001
    Bisgard, KM
    Rhodes, P
    Connelly, BL
    Bi, DL
    Hahn, C
    Patrick, S
    Glodé, MP
    Ehresmann, KR
    [J]. PEDIATRICS, 2005, 116 (02) : E285 - E294
  • [3] Infant pertussis - Who was the source?
    Bisgard, KM
    Pascual, FB
    Ehresmann, KR
    Miller, CA
    Cianfrini, C
    Jennings, CE
    Rebmann, CA
    Gabel, J
    Schauer, SL
    Lett, SM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (11) : 985 - 989
  • [4] Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1
  • [5] CARO JJ, 2005, INFECT DIS J S5, V24, pS75
  • [6] The science and fiction of the "resurgence" of pertussis
    Cherry, JD
    [J]. PEDIATRICS, 2003, 112 (02) : 405 - 406
  • [7] Measles dynamics and vaccination diffusionA model and an application
    Laurent Coudeville
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (4): : 319 - 326
  • [8] Fiore Anthony E., 2006, Morbidity and Mortality Weekly Report, V55, P1
  • [9] An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults
    Halperin, SA
    Smith, B
    Russell, M
    Hasselback, P
    Guasparini, R
    Skowronski, D
    Meekison, W
    Parker, R
    Lavigne, P
    Barreto, L
    [J]. VACCINE, 2000, 18 (14) : 1312 - 1319
  • [10] An age-structured model for pertussis transmission
    Hethcote, HW
    [J]. MATHEMATICAL BIOSCIENCES, 1997, 145 (02) : 89 - 136